PALVELLA THERAPEUTICS, INC. ($PVLA)
Filing Information
| Accession Number | 0001104659-26-006237 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 23, 2026 |
| Document Date | Jan 21, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
12,906
Total Value
$454,866.43
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Jan 21, 2026 | Exercise/Conversion | 2,154 | $7.14 | $15,379.56 | 2,154 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jan 21, 2026 | Exercise/Conversion | 2,148 | $9.08 | $19,503.84 | 4,302 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jan 21, 2026 | Sale | 553 | $95.49 | $52,805.97 | 3,749 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jan 21, 2026 | Sale | 3,749 | $97.94 | $367,177.06 | 0 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Jan 21, 2026 | Exercise/Conversion | 2,154 | $0.00 | $0.00 | 19,397 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Jan 21, 2026 | Exercise/Conversion | 2,148 | $0.00 | $0.00 | 19,332 | Direct | โ | View Details |